The capital turnover (annual revenue relative to shareholder's equity) for NEOS is -3.83 -- better than just 3% of US stocks.
NEOS's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 1.96% of US stocks.
Neos Therapeutics Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 28.77%, greater than the shareholder yield of 90.27% of stocks in our set.
Stocks that are quantitatively similar to NEOS, based on their financial statements, market capitalization, and price volatility, are IO, DBD, TXMD, MNKD, and AQST.
NEOS's SEC filings can be seen here. And to visit Neos Therapeutics Inc's official web site, go to www.neostx.com.
Neos Therapeutics develops, manufactures, and commercializes products for the treatment of attention deficit hyperactivity disorder (ADHD) using its drug delivery technologies. The company was founded in 2008 and is based in Grand Prairie, Texas.
DALLAS and FORT WORTH, Texas, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products, today announced that Jerry McLaughlin, President and Chief Executive Officer, will participate in a fireside chat at the Cantor Virtual Global Healthcare Conference on Wednesday, September 16, 2020, at 3:40 p.m. ET. A live webcast of the fireside chat will be available on the Investor Relations page of the company’s website at http://investors.neostx.com/. Following the presentation, a replay of the webcast will be available on Neos’ website for 30 days. About Neos Therapeutics Neos Therapeutics, Inc. (NASDAQ: NEOS) is a commercial-stage pharmaceutical company developing...
Neos Therapeutics' (NEOS) share price has crashed as a result of the pandemic, but contrary to most other pharma companies, its share price hasn't recovered: The main reasons for the share price collapse are the pandemic and unusually low wholesale inventory levels, producing declines in subscriptions. However, both of these...
Shareholders Unite on Seeking Alpha | July 14, 2020
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each stock might be going. […]